Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use Disorders
酒精使用障碍治疗后的止痛药处方和滥用
基本信息
- 批准号:10201106
- 负责人:
- 金额:$ 36.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAcuteAcute PainAddressAdherenceAdmission activityAdultAdverse eventAgeAlcohol abuseAlcohol consumptionAlcohol dependenceAlcohol or Other Drugs useAlcoholismAlcoholsAnalgesicsBenzodiazepinesCessation of lifeChronicClientClinicalDataData SetDatabasesDiagnosisDiseaseDoseDropoutDrug usageExhibitsFailureFamily history ofFeelingGoalsHealthIndividualInformation SystemsInjuryLeadLinkMedicaidMedicalMental disordersMorbidity - disease rateMotivationNatureNew YorkOpioidOverdosePainPatientsPharmaceutical PreparationsPharmacotherapyPhysiciansPopulationPrevalencePrimary Health CarePropertyRecording of previous eventsRecordsRegimenRelapseReportingRiskSamplingSeriesServicesSubstance Use DisorderSubstance abuse problemSystemTestingTimeTreatment FactorUpdateViolenceadverse outcomealcohol abuse therapyalcohol availabilityalcohol involvementalcohol use disorderchronic alcohol ingestionchronic paindrug misuseemotional abuseexperiencehigh riskmisuse of prescription only drugsmortalityneural circuitopioid misusephysical abusepolicy implicationprescription opioidproblem drinkerrelapse predictiontreatment programtreatment services
项目摘要
Abstract
There are critical links between alcohol use disorder (AUD) and pain that have been largely ignored until
recently. For example, individuals with alcohol dependence often experience physical injuries from accidents
and violence that have a lasting physical impact. Chronic alcohol use can also lead to physical conditions that
produce significant pain. Similarly, AUDs can also lead to poor adherence to medical regimens for diseases
which can result in exacerbation in pain. Finally, given that common neural circuits are impacted by chronic
pain and by alcohol dependence, alcohol dependence may lead to heightened feelings of pain, and that such
pain may lead to alcohol use for its analgesic properties. Given these linkages between AUDs and chronic
pain, it is not surprising to find significant proportions of individuals with AUD report that they experience
significant pain and are in treatment for chronic pain. The presence of chronic pain among individuals with
AUD, combined with the chronic, relapsing nature of alcohol use disorders raises the possibility that individuals
with an alcohol use disorder may seek treatment for chronic pain, receive opioid and/or benzodiazepine
prescriptions for pain, and be at risk for morbidity and mortality associated with using these medications,
particularly in conjunction with excessive alcohol use. This study proposes to integrate records from the Client
Data System of the New York State Office of Alcoholism and Substance Abuse Services (OASAS) patient
records with New York State Medicaid records. We plan to identify approximately 214,000 Medicaid patients
with a first contact with the OASAS treatment system from 2006-2014 and merge these treatment records with
their Medicaid claims records from their initial treatment contact through 2015. In addition, we will draw a
sample three times as large of matched individuals from the Medicaid claims to serve as a comparison sample.
Hypotheses will address the extent to which individuals with a history of treatment for alcohol problems are at
increased risk for receiving prescriptions for opioids and benzodiazepine for pain and whether this is because
of an increased risk of pain diagnoses, or whether this risk remains after controlling for diagnoses. We will also
determine if alcohol treatment patients are at further risk for higher doses, longer durations, and
misuse/overdose from these substances, and whether pain diagnoses account for this risk. Moreover, the
integration of these datasets will allow us to identify factors in the existing treatment records that would identify
individuals most at risk for the excessive use and misuse of these medications. These findings will have
important clinical implications for the management of patients in primary care with an unrecognized history of
an alcohol use disorder and policy implications with respect to medical access to alcohol treatment records.
抽象的
酒精使用障碍 (AUD) 和疼痛之间存在重要联系,但直到现在,这些联系在很大程度上都被忽视了。
最近。例如,酒精依赖者经常会因事故而遭受身体伤害
以及对身体造成持久影响的暴力。长期饮酒也会导致身体状况
产生明显的疼痛。同样,AUD 也会导致疾病治疗的依从性较差
这可能会导致疼痛加剧。最后,考虑到常见的神经回路受到慢性病的影响
疼痛和酒精依赖,酒精依赖可能会导致疼痛感加剧,并且这种情况
疼痛可能会导致饮酒,因为它具有镇痛作用。鉴于澳元与慢性病之间的这些联系
痛苦,毫不奇怪地发现很大一部分患有 AUD 的人报告说他们经历过
严重疼痛并正在治疗慢性疼痛。患有慢性疼痛的个体存在
AUD,加上酒精使用障碍的慢性、复发性,增加了个体以下可能性:
患有酒精使用障碍的人可能会寻求慢性疼痛的治疗,接受阿片类药物和/或苯二氮卓类药物
治疗疼痛的处方,并面临与使用这些药物相关的发病率和死亡风险,
特别是与过量饮酒有关。本研究建议整合客户的记录
纽约州酗酒和药物滥用服务办公室 (OASAS) 患者数据系统
记录与纽约州医疗补助记录。我们计划识别大约 214,000 名医疗补助患者
2006-2014 年首次接触 OASAS 治疗系统,并将这些治疗记录与
他们从最初接触治疗到 2015 年的医疗补助索赔记录。此外,我们将绘制一份
从医疗补助声称中抽取三倍大的匹配个体作为比较样本。
假设将解决有酗酒问题治疗史的个体在多大程度上处于酒精问题的状态。
接受阿片类药物和苯二氮卓类止痛处方的风险增加,这是否是因为
疼痛诊断的风险增加,或者在控制诊断后这种风险是否仍然存在。我们还将
确定酒精治疗患者是否因更高剂量、更长持续时间而面临进一步风险,以及
这些物质的误用/过量,以及疼痛诊断是否会导致这种风险。此外,
这些数据集的整合将使我们能够识别现有治疗记录中的因素,从而确定
最有可能过度使用和滥用这些药物的人。这些发现将有
对于初级保健中具有未识别病史的患者的管理具有重要的临床意义
酒精使用障碍以及对酒精治疗记录的医疗获取的政策影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER L. ELKIN其他文献
PETER L. ELKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER L. ELKIN', 18)}}的其他基金
National Library of Medicine Conference 2022
2022 年国家医学图书馆会议
- 批准号:
10526993 - 财政年份:2022
- 资助金额:
$ 36.07万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
布法罗基因组和医疗保健技术研究创新 (BRIGHT) 短期培训和教育
- 批准号:
10707232 - 财政年份:2022
- 资助金额:
$ 36.07万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
布法罗基因组和医疗保健技术研究创新 (BRIGHT) 短期培训和教育
- 批准号:
10631367 - 财政年份:2022
- 资助金额:
$ 36.07万 - 项目类别:
Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use Disorders
酒精使用障碍治疗后的止痛药处方和滥用
- 批准号:
10224040 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use Disorders
酒精使用障碍治疗后的止痛药处方和滥用
- 批准号:
10442656 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
10205171 - 财政年份:2017
- 资助金额:
$ 36.07万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
10617368 - 财政年份:2017
- 资助金额:
$ 36.07万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
9552954 - 财政年份:2017
- 资助金额:
$ 36.07万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
10405911 - 财政年份:2017
- 资助金额:
$ 36.07万 - 项目类别:
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 36.07万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10778757 - 财政年份:2023
- 资助金额:
$ 36.07万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10783106 - 财政年份:2023
- 资助金额:
$ 36.07万 - 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
- 批准号:
10740796 - 财政年份:2023
- 资助金额:
$ 36.07万 - 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
- 批准号:
10599401 - 财政年份:2022
- 资助金额:
$ 36.07万 - 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
- 批准号:
575854-2022 - 财政年份:2022
- 资助金额:
$ 36.07万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
- 批准号:
467076 - 财政年份:2021
- 资助金额:
$ 36.07万 - 项目类别:
Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
9979265 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
10218273 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:














{{item.name}}会员




